MoneyWorks4Me

Sequent Scientific - Quaterly Results

11 Feb 2022 Evaluate
A decrease in the sales to Rs. 591.91 millions was observed for the quarter ended December 2021. The sales stood at Rs. 684.61 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 44.73 millions from Rs. 117.25 millions, a decline of -61.85% on QoQ basis.The company reported a degrowth in operating Profit to 84.76 millions from 183.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 591.91 684.61 -13.54 1559.53 1959.78 -20.42 2654.57 2273.33 16.77
Other Income 56.97 56.69 0.49 218.71 140.45 55.72 199.66 145.61 37.12
PBIDT 84.76 183.20 -53.73 159.07 464.57 -65.76 552.56 367.98 50.16
Interest 5.56 6.02 -7.64 10.02 24.30 -58.77 26.80 50.35 -46.77
PBDT 79.20 177.18 -55.30 149.05 413.79 -63.98 500.15 317.63 57.46
Depreciation 24.04 21.93 9.62 72.52 65.21 11.21 91.28 89.50 1.99
PBT 55.16 155.25 -64.47 76.53 348.58 -78.05 408.87 228.13 79.23
TAX 10.43 38.00 -72.55 -4.98 73.88 -106.74 87.74 14.72 496.06
Deferred Tax -2.91 10.53 -127.64 2.16 21.22 -89.82 26.89 -17.11 -257.16
PAT 44.73 117.25 -61.85 81.51 274.70 -70.33 321.13 213.41 50.48
Equity 496.74 496.74 0.00 496.74 496.74 0.00 496.74 496.74 0.00
PBIDTM(%) 14.32 26.76 -46.49 10.20 23.71 -56.97 20.82 16.19 28.59
Peers
Company Name CMP
Sun Pharma. Inds. 1849.60
Dr. Reddys Labs. 1211.70
Cipla 1381.75
Lupin 2117.40
Zydus Lifesciences 1164.25
View more..